Heart failure & cardiomyopathies

Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators

Circ Heart FailPublished Prospective cohort study

Main finding · Primary composite outcomeResult — go to the resultHazard ratio 2.61 95% CI 1.35–5.04

Authors' conclusion

Elevated dd-cfDNA and cell-free mitochondrial DNA after heart transplant may mechanistically be implicated in the higher incidence of AR and worse clinical outcomes in Black transplant recipients.

Study context

Population
Heart transplant recipients (GRAfT cohort)
Participants
148 recipients
Exposure
Black vs White heart transplant recipients
  • Blackn = 65
  • Whiten = 83reference
Outcome
Composite of:
  • Acute rejection (AR)
  • Graft dysfunction (LVEF <50% and decrease by ≥10%)
  • Death
Follow-up
1 and 2 years
Methodological detailsmulticentre, longitudinal
  • Multicentre
  • Longitudinal

Main finding

Primary composite outcome

Hazard ratio

2.61

95% CI 1.35–5.04

P = 0.004

By group

Black

1 year
43%
2 years
55%

White

1 year
23%
2 years
27%

1 year

Black43%
White23%

2 years

Black55%
White27%
Blackvs White
HR 2.61 (95% CI 1.35–5.04); P = 0.004

As reported in the abstract

%donor-derived cell-free DNA (dd-cfDNA) associated with primary composite outcome
multivariable HR 1.15 (95% CI 1.03-1.28, P=0.010)

Observational data: associations, not effects.

Further findings

AR incidence

P = 0.002

Antibody-mediated rejection prevalence

P < 0.001

Cell-free mitochondrial DNA

P < 0.001

OutcomeBlackWhiteP value
dd-cfDNA after transplant0.09% (IQR 0.001–0.30)0.05% (IQR 0.001–0.23)P = 0.003

dd-cfDNA after transplant

Beyond 6 months, persistent rise in dd-cfDNA with higher levels in Black patients

Original publication

Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators. Circ Heart Fail. Published 20 February 2024. doi:10.1161/circheartfailure.123.011160

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.